Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Biol Psychiatry ; 91(9): 810-820, 2022 05 01.
Article in English | MEDLINE | ID: mdl-35090617

ABSTRACT

BACKGROUND: Depression is pleiotropic and influenced by diverse genetic, environmental, and pharmacological factors. Identifying patterns of circuit activity on which many of these factors converge would be important, because studying these patterns could reveal underlying pathophysiological processes and/or novel therapies. Depression is commonly assumed to involve changes within prefrontal circuits, and dopamine D2 receptor (D2R) agonists are increasingly used as adjunctive antidepressants. Nevertheless, how D2Rs influence disease-relevant patterns of prefrontal circuit activity remains unknown. METHODS: We used brain slice calcium imaging to measure how patterns of prefrontal activity are modulated by D2Rs, antidepressants, and manipulations that increase depression susceptibility. To validate the idea that prefrontal D2Rs might contribute to antidepressant responses, we used optogenetic and genetic manipulations to test how dopamine, D2Rs, and D2R+ neurons contribute to stress-coping behavior. RESULTS: Patterns of positively correlated activity in prefrontal microcircuits are specifically enhanced by D2R stimulation as well as by two mechanistically distinct antidepressants, ketamine and fluoxetine. Conversely, this D2R-driven effect was disrupted in two etiologically distinct depression models, a genetic susceptibility model and mice that are susceptible to chronic social defeat. Phasic stimulation of dopaminergic afferents to the prefrontal cortex and closed-loop stimulation of D2R+ neurons increased effortful responses to tail suspension stress, whereas prefrontal D2R deletion reduced the duration of individual struggling episodes. CONCLUSIONS: Correlated prefrontal microcircuit activity represents a point of convergence for multiple depression-related manipulations. Prefrontal D2Rs enhance this activity. Through this mechanism, prefrontal D2Rs may promote network states associated with antidepressant actions and effortful responses to stress.


Subject(s)
Dopamine , Receptors, Dopamine D2 , Adaptation, Psychological , Animals , Mice , Neurons/physiology , Prefrontal Cortex/metabolism , Receptors, Dopamine D2/metabolism
2.
J Neurosci ; 40(11): 2215-2227, 2020 03 11.
Article in English | MEDLINE | ID: mdl-31988060

ABSTRACT

Manipulations that enhance GABAergic inhibition have been associated with improved behavioral phenotypes in autism models, suggesting that autism may be treated by correcting underlying deficits of inhibition. Interneuron transplantation is a method for increasing recipient synaptic inhibition, and it has been considered a prospective therapy for conditions marked by deficient inhibition, including neuropsychiatric disorders. It is unknown, however, whether interneuron transplantation may be therapeutically effective only for conditions marked by reduced inhibition, and it is also unclear whether transplantation improves behavioral phenotypes solely by normalizing underlying circuit defects. To address these questions, we studied the effects of interneuron transplantation in male and female mice lacking the autism-associated gene, Pten, in GABAergic interneurons. Pten mutant mice exhibit social behavior deficits, elevated synaptic inhibition in prefrontal cortex, abnormal baseline and social interaction-evoked electroencephalogram (EEG) signals, and an altered composition of cortical interneuron subtypes. Transplantation of wild-type embryonic interneurons from the medial ganglionic eminence into the prefrontal cortex of neonatal Pten mutants rescued social behavior despite exacerbating excessive levels of synaptic inhibition. Furthermore, transplantation did not normalize recipient EEG signals measured during baseline states. Interneuron transplantation can thus correct behavioral deficits even when those deficits are associated with elevated synaptic inhibition. Moreover, transplantation does not exert therapeutic effects solely by restoring wild-type circuit states. Our findings indicate that interneuron transplantation could offer a novel cell-based approach to autism treatment while challenging assumptions that effective therapies must reverse underlying circuit defects.SIGNIFICANCE STATEMENT Imbalances between neural excitation and inhibition are hypothesized to contribute to the pathophysiology of autism. Interneuron transplantation is a method for altering recipient inhibition, and it has been considered a prospective therapy for neuropsychiatric disorders, including autism. Here we examined the behavioral and physiological effects of interneuron transplantation in a mouse genetic model of autism. They demonstrate that transplantation rescues recipient social interaction deficits without correcting a common measure of recipient inhibition, or circuit-level physiological measures. These findings demonstrate that interneuron transplantation can exert therapeutic behavioral effects without necessarily restoring wild-type circuit states, while highlighting the potential of interneuron transplantation as an autism therapy.


Subject(s)
Autistic Disorder/surgery , Brain Tissue Transplantation , Fetal Tissue Transplantation , GABAergic Neurons/physiology , Interneurons/transplantation , Neural Inhibition/physiology , PTEN Phosphohydrolase/deficiency , Social Behavior , Animals , Autistic Disorder/physiopathology , Autistic Disorder/psychology , Disease Models, Animal , Electroencephalography , Exploratory Behavior , Female , Male , Maze Learning , Median Eminence/cytology , Median Eminence/embryology , Mice , Mice, Knockout , PTEN Phosphohydrolase/physiology , Patch-Clamp Techniques , Phenotype , Prefrontal Cortex/physiopathology , Random Allocation , Synapses/physiology
3.
Cell Rep ; 24(2): 278-283, 2018 07 10.
Article in English | MEDLINE | ID: mdl-29996089

ABSTRACT

Avoidance of potentially toxic food by means of conditioned taste aversion is critical for survival of many animals. However, the underlying neuronal mechanisms are poorly understood. Here, using two-photon calcium imaging of defined gustatory cortex neurons in vivo, we show that conditioned taste aversion dynamically shifts neuronal population coding by stimulus-specific recruitment of neurons that project to the basolateral amygdala.


Subject(s)
Amygdala/physiology , Avoidance Learning/physiology , Conditioning, Classical , Nerve Net/physiology , Taste/physiology , Animals , Imaging, Three-Dimensional , Male , Mice, Inbred C57BL
4.
Life Sci ; 90(25-26): 995-1000, 2012 Jun 27.
Article in English | MEDLINE | ID: mdl-22683433

ABSTRACT

AIMS: Anxiety and stress disorders are currently among the ten most important public health concerns, and in recent years, have reached epidemic proportions. The current success rate of treatments for anxiety disorders is not high, reaching 50% at most. These treatments are also associated with a wide variety of side effects. The aim of the present study was to investigate the anxiolytic properties of a novel herbal treatment produced in our laboratory compared to a conventional treatment for anxiety disorders, namely SSRIs. MAIN METHODS: Anxiety-like behavior was evaluated in adult mice exposed to stress during childhood following 1, 2 and 3 weeks of treatment with the novel herbal treatment or escitalopram, using the novel open field and the elevated plus maze paradigms. The behavioral evaluation in these mice was followed by a biochemical assessment of their brain hippocampal BDNF levels and blood corticosterone levels. KEY FINDINGS: The study showed that (1) the novel herbal treatment reduced anxiety-like behaviors in both behavioral tests. Interestingly, this reduction was observed only following a 3-week treatment; (2) following the novel treatment, corticosterone levels in the plasma of treated mice were reduced and this reduction was similar to the one observed following escitalopram treatment; and (3) BDNF levels in the hippocampus of mice treated both with the novel herbal treatment and escitalopram were increased. SIGNIFICANCE: These behavioral and biological findings indicate that our novel herbal compound has the potential of being highly efficacious in treating anxiety disorders.


Subject(s)
Anti-Anxiety Agents/therapeutic use , Anxiety/drug therapy , Plant Preparations/therapeutic use , Animals , Anti-Anxiety Agents/pharmacology , Anxiety/blood , Anxiety/psychology , Corticosterone/blood , Disease Models, Animal , Male , Maze Learning/drug effects , Maze Learning/physiology , Mice , Mice, Inbred BALB C , Plant Preparations/pharmacology , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...